Literature DB >> 17418413

A conditional mouse model of synovial sarcoma: insights into a myogenic origin.

Malay Haldar1, Jeffrey D Hancock, Cheryl M Coffin, Stephen L Lessnick, Mario R Capecchi.   

Abstract

Synovial sarcoma is an aggressive soft-tissue malignancy marked by a unique t(X;18) translocation leading to expression of a chimeric SYT-SSX fusion protein. We report here a mouse model of synovial sarcoma based on conditional expression of the human SYT-SSX2. Using this model, we have identified myoblasts as a potential source of synovial sarcoma. Remarkably, within the skeletal muscle lineage, while expression of the oncoprotein in immature myoblasts leads to induction of synovial sarcoma with 100% penetrance, its expression in more differentiated cells induces myopathy without tumor induction. We also show that early widespread expression of the fusion protein disrupts normal embryogenesis, causing lethality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418413     DOI: 10.1016/j.ccr.2007.01.016

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  122 in total

Review 1.  Modeling sarcomagenesis using multipotent mesenchymal stem cells.

Authors:  Rene Rodriguez; Ruth Rubio; Pablo Menendez
Journal:  Cell Res       Date:  2011-09-20       Impact factor: 25.617

Review 2.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

3.  Liver kinase B1 inhibits the expression of inflammation-related genes postcontraction in skeletal muscle.

Authors:  Ting Chen; Timothy M Moore; Mark T W Ebbert; Natalie L McVey; Steven R Madsen; David M Hallowell; Alexander M Harris; Robin E Char; Ryan P Mackay; Chad R Hancock; Jason M Hansen; John S Kauwe; David M Thomson
Journal:  J Appl Physiol (1985)       Date:  2016-01-21

Review 4.  Advances in sarcoma genomics and new therapeutic targets.

Authors:  Barry S Taylor; Jordi Barretina; Robert G Maki; Cristina R Antonescu; Samuel Singer; Marc Ladanyi
Journal:  Nat Rev Cancer       Date:  2011-07-14       Impact factor: 60.716

5.  The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.

Authors:  Roy Barco; Laura B Hunt; Andrea L Frump; Christina B Garcia; Andrew Benesh; Robert L Caldwell; Josiane E Eid
Journal:  Mol Biol Cell       Date:  2007-08-08       Impact factor: 4.138

6.  Molecular biology and therapeutics in musculoskeletal oncology.

Authors:  Theresa A Guise; Regis O'Keefe; R Lor Randall; Richard M Terek
Journal:  J Bone Joint Surg Am       Date:  2009-03-01       Impact factor: 5.284

7.  Mitochondrial and performance adaptations to exercise training in mice lacking skeletal muscle LKB1.

Authors:  Colby B Tanner; Steven R Madsen; David M Hallowell; Darren M J Goring; Timothy M Moore; Shalene E Hardman; Megan R Heninger; Daniel R Atwood; David M Thomson
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-08-27       Impact factor: 4.310

Review 8.  The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.

Authors:  Jilong Yang; Zhiwu Ren; Xiaoling Du; Mengze Hao; Wenya Zhou
Journal:  Stem Cell Investig       Date:  2014-10-27

Review 9.  Neuronal differentiation of synovial sarcoma and its therapeutic application.

Authors:  Tatsuya Ishibe; Tomitaka Nakayama; Tomoki Aoyama; Takashi Nakamura; Junya Toguchida
Journal:  Clin Orthop Relat Res       Date:  2008-06-19       Impact factor: 4.176

Review 10.  Synovial sarcoma: from genetics to genetic-based animal modeling.

Authors:  Malay Haldar; R Lor Randall; Mario R Capecchi
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.